Back to feed
National Law Review
National Law Review
7/24/2026
Healthcare Policy Update: House and Senate Advance Transparency and Drug Pricing Bills

Healthcare Policy Update: House and Senate Advance Transparency and Drug Pricing Bills

Original: McDermott+ Check-Up: July 24, 2026

Short summary

This weekly healthcare policy update covers House Energy and Commerce Committee advancing 29 bills including the Lower Costs More Transparency Act, and Senate HELP Committee advancing transparency and drug pricing legislation. HHS announced over $1 billion in Medicaid deferrals for California and Minnesota. CMS issued a proposed rule capping Medicaid provider taxes in expansion states.

  • House E&C advanced the Lower Costs, More Transparency Act with 10 healthcare bills by unanimous vote
  • Senate HELP advanced transparency and drug pricing bills including the Patients Deserve Price Tags Act
  • HHS deferred over $1B in Medicaid funding; CMS proposed capping provider taxes in expansion states

Generated with AI, which can make mistakes.

Is this a good recommendation for you?

Comments

Failed to load comments. Please try again.

Explore more